At TheraSonic, we transform the treatment of brain diseases by enabling drug delivery to the brain using non-invasive focused ultrasound.
Discover our technology
The blood-brain barrier (BBB) acts as a critical defense mechanism against harmful substances. However, this selectivity also impedes the delivery of therapeutic agents to the brain, a significant challenge in treating neurological disorders.
TheraSonic non-invasive device transiently disrupts the BBB using low-intensity focused ultrasound which facilitates the delivery of therapeutics at targeted locations in the brain.
Backed by over 15 years of academic research, this innovative technology enables non-invasive delivery of therapeutics to targeted areas of the brain.
Our real-time dosimetry solution ensures safe disruption of the blood-brain barrier using focused ultrasound for repeated treatments.
Based on state-of-the-art neuro-navigation solution, our system ensures precise targeting in the brain.
Leveraging our medical robot technology, our platform enables treatment of multiple targets and large volume in a single session.
Meet the talented individuals behind our groundbreaking medical device that aims to enhance drug delivery to the brain.
Chairwoman of the strategic committee
Founder & CEO, TheraSonic
Independent board member
M2care, Managing Partner
Gustave Roussy Transfert, COO
TheraSonic is created as a spin-off from CEA and CNRS research.
1M€ raised led by M2care with Gustave Roussy Transfert.
Participated at the Annual International Symposium on Therapeutic Ultrasound.
Won the Prix du Public at the SNITEM startup innovation day.
Featured by CEA at the French-German Tech Lab.
CEO Benoit Larrat featured on "La France bouge".
Geraldine Le Duc appointed as chairwoman.
Winner of the Trophée Jeune Entreprise HealthTech, awarded by France Biotech.
TheraSonic receives official authorisation for its First-in-Human clinical trial sponsored by Gustave Roussy hospital.
TheraSonic has grown amongst leaders and innovators in their respective field.
Interview "La France bouge" - Europe 1
Prix du Public - SNITEM Startup Day 2025
Winner - Trophée Jeune Entreprise HealthTech 2026
Featured at VivaTech 2025 - CEA Selection
We’re proud to announce the appointment of Geraldine Le Duc as the new Chairwoman of Therasonic’s Strategic Committee. Geraldine brings ov…
Read more : TheraSonic appoints Geraldine Le Duc as chairwoman of its strategic committeeWe are thrilled to announce that TheraSonic will be participating in the Annual International Symposium on Therapeutic Ultrasound organised by the Int…
Read more : Therasonic to participate at the Annual Symposium on Therapeutic Ultrasound at Taipei, TaiwanTheraSonic will be present at the Robotique Medicale Made In France conference on October 9 in Montpellier. This not-to-be-missed event brings togethe…
Read more : TheraSonic participates to Robotique Medicale Made In France Conference
